InterCure H1 Revenue NIS125.733M Down From NIS208.614M YoY, Adjusted EBITDA NIS20.829M Down From NIS29.669M YoY
Portfolio Pulse from Benzinga Newsdesk
InterCure's H1 2024 revenue decreased due to damages from a terrorist attack and war, but they are receiving compensation from Israeli authorities. They are expanding their partnership with Cookies™ to Germany and expect growth in H2 2024.
August 30, 2024 | 8:13 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
InterCure's H1 2024 revenue fell due to external damages, but they are receiving compensation. Expansion with Cookies™ to Germany and UK markets is expected to drive growth in H2 2024.
InterCure's revenue drop is attributed to external factors, but they are receiving compensation. The strategic expansion with Cookies™ to Germany and the UK is expected to drive growth, indicating a positive outlook for H2 2024.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100